In addition, significant changes in p97/VCP expression have been observed in many cancer types, and the use of proteasome inhibitors, such as bortezomib, or p97/VCP inhibitors, such as DBeQ, has been suggested in the treatment of cancer or cancerous tissue. The gene discussed is VCP; the disease is cancer.